4.7 Article

The Landscape of Persistent Viral Genomes in ART-Treated SIV, SHIV, and HIV-2 Infections

期刊

CELL HOST & MICROBE
卷 26, 期 1, 页码 73-+

出版社

CELL PRESS
DOI: 10.1016/j.chom.2019.06.005

关键词

-

资金

  1. NIH [UM1 AI126603, UM1 AI126620, UM1 AI12661, PPG MH070306, NS077869, NS076357, U19-0AI076113, R56 AI118753, 1R01AI127142, T32 GM007445, T32 AI007291-27]
  2. Howard Hughes Medical Institute
  3. Bill and Melinda Gates Foundation [OPP1115715]
  4. NCRR
  5. Office of Research Infrastructure Programs (ORIP) of the NIH [P40 OD013117]
  6. National Cancer Institute, NIH [HSN261200800001E]
  7. NIH/NIAID [AI120765, AI060466]

向作者/读者索取更多资源

Evaluation of HIV cure strategies is complicated by defective proviruses that persist in ART-treated patients but are irrelevant to cure. Non-human primates (NHP) are essential for testing cure strategies. However, the persisting proviral landscape in ART-treated NHPs is uncharacterized. Here, we describe viral genomes persisting in ART-treated, simian immunodeficiency virus (SIV)-infected NHPs, simian-human immunodeficiency virus (SHIV)-infected NHPs, and humans infected with HIV-2, an SIV-related virus. The landscapes of persisting SIV, SHIV, and HIV-2 genomes are also dominated by defective sequences. However, there was a significantly higher fraction of intact SIV proviral genomes compared to ART-treated HIV-1 or HIV-2 infected humans. Compared to humans with HIV-1, SIV-infected NHPs had more hypermutated genomes, a relative paucity of clonal SIV sequences, and a lower frequency of deleted genomes. Finally, we report an assay for measuring intact SIV genomes which may have value in cure research.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据